Share This Video

Native GLP-1: Impact on the Incretin Effect

In this video, Dr. Ralph DeFronzo describes the essential role of incretin hormones GLP-1 and GIP in the maintenance of normal glucose homeostasis and the regulation of insulin secretion. He discusses impairment of the incretin effect in patients with type 2 diabetes and shows data related to the benefit of GLP-1 administration.
Ralph DeFronzo, MD
Professor of Medicine and Chief of the Diabetes Division at the University of Texas Health Science Center
San Antonio, Texas
Ralph DeFronzo, MD


  1. Nauck M, Stöckmann F, Ebert R, Creutzfeldt W. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia. 1986;29(1):46–52.
  2. Campbell JE, Drucker DJ. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab. 2013;17(6):819-837.
  3. DeFronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58(4):773-795.
  4. Vilsbøll T, Krarup T, Madsbad S, Holst JJ. Defective amplification of the late phase insulin response to glucose by GIP in obese type II diabetic patients. Diabetologia. 2002;45(8):1111–1119.